A clinical trial is a research study that determines the safety and efficacy of a new treatment. In a clinical trial participants are assigned to receive specific interventions according to a research plan, or protocol, created by an investigator, who is often a physician. When a new product or approach is being studied, it is not known whether it will be helpful, harmful, or no different than available alternatives, so investigators determine the safety and efficacy of the intervention by measuring certain outcomes in the participants. Clinical trials can be sponsored, or funded, by pharmaceutical companies, academic medical centers, voluntary groups, and other organizations.1, 2

For more information about clinical trials, visit clinicaltrials.gov.


ImmunoGen-sponsored clinical trials include the following:

Compound: mirvetuximab soravtansine (IMGN853)
Target: FRα
Cancer type(s): Ovarian

Compound: IMGN779
Target: CD33
Cancer type(s): Acute myeloid leukemia (AML)

Compound: IMGN632
Target: CD123
Cancer type(s): AML, Blastic Plamacytoid Dendritic Cell Neoplasm (BPDCN

Our partners are also conducting clinical trials with compounds using our antibody-drug conjugate technology.

More information

If you are a patient considering participating in a clinical trial, consult with your doctor who can provide you with more information and help determine whether a clinical trial is appropriate for you.

If you are a physician or other healthcare provider, you can contact our Scientific Affairs team (scientificaffairs@immunogen.com) for more information about our clinical trials.

You are now leaving this website. If you would like to continue, click Continue.